Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Boyd

Showing results (1151-1160 of 1,228) with videos related to

Pageof 123
Sort By:
Applied Clinical Informatics|November 7, 2024
Collection of Patient-Reported Outcome Measures in Rural and Underserved PopulationsAndrea Cheville, Crystal L Patil, Andrew D Boyd, et al.
Contemporary Clinical Trials|December 31, 2023
Collecting patient-reported outcome measures in the electronic health record: Lessons from the NIH pragmatic trials CollaboratoryChristina K Zigler, Oluwaseun Adeyemi, Andrew D Boyd, et al.
Medrxiv : the Preprint Server for Health Sciences|April 14, 2021
mRNA vaccination compared to infection elicits an IgG-predominant response with greater SARS-CoV-2 specificity and similar decrease in variant spike recognitionKatharina Röltgen, Sandra C A Nielsen, Prabhu S Arunachalam, et al.
JCI Insight|March 8, 2024
Impaired innate and adaptive immune responses to BNT162b2 SARS-CoV-2 vaccination in systemic lupus erythematosusKavita Y Sarin, Hong Zheng, Yashaar Chaichian, et al.
Blood Cancer Journal|December 10, 2016
Second malignancies in the context of lenalidomide treatment: an analysis of 2732 myeloma patients enrolled to the Myeloma XI trialJ R Jones, D A Cairns, W M Gregory, et al.
British Journal of Haematology|March 29, 2014
Osteonecrosis of the jaw and renal safety in patients with newly diagnosed multiple myeloma: Medical Research Council Myeloma IX Study resultsGraham H Jackson, Gareth J Morgan, Faith E Davies, et al.
Cellular & Molecular Immunology|January 5, 2022
Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primatesStéphane Pillet, Prabhu S Arunachalam, Guadalupe Andreani, et al.
Journal of the American Medical Informatics Association : JAMIA|October 1, 2021
Enhancing the use of EHR systems for pragmatic embedded research: lessons from the NIH Health Care Systems Research CollaboratoryRachel L Richesson, Keith S Marsolo, Brian J Douthit, et al.
Annals of the Rheumatic Diseases|July 14, 2026
Zanubrutinib monotherapy for IgG4-related head and neck diseaseMatthew C Baker, Saurabh Gawde, Audra Horomanski, et al.
Haematologica|July 23, 2013
Comprehensive whole-genome sequencing of an early-stage primary myelofibrosis patient defines low mutational burden and non-recurrent candidate genesJason D Merker, Krishna M Roskin, Dana Ng, et al.
Pageof 123

Showing results (1151-1160 of 1,228) with videos related to

Sort By:
Pageof 123
Applied Clinical Informatics|November 7, 2024
Collection of Patient-Reported Outcome Measures in Rural and Underserved PopulationsAndrea Cheville, Crystal L Patil, Andrew D Boyd, et al.
Contemporary Clinical Trials|December 31, 2023
Collecting patient-reported outcome measures in the electronic health record: Lessons from the NIH pragmatic trials CollaboratoryChristina K Zigler, Oluwaseun Adeyemi, Andrew D Boyd, et al.
Medrxiv : the Preprint Server for Health Sciences|April 14, 2021
mRNA vaccination compared to infection elicits an IgG-predominant response with greater SARS-CoV-2 specificity and similar decrease in variant spike recognitionKatharina Röltgen, Sandra C A Nielsen, Prabhu S Arunachalam, et al.
JCI Insight|March 8, 2024
Impaired innate and adaptive immune responses to BNT162b2 SARS-CoV-2 vaccination in systemic lupus erythematosusKavita Y Sarin, Hong Zheng, Yashaar Chaichian, et al.
Blood Cancer Journal|December 10, 2016
Second malignancies in the context of lenalidomide treatment: an analysis of 2732 myeloma patients enrolled to the Myeloma XI trialJ R Jones, D A Cairns, W M Gregory, et al.
British Journal of Haematology|March 29, 2014
Osteonecrosis of the jaw and renal safety in patients with newly diagnosed multiple myeloma: Medical Research Council Myeloma IX Study resultsGraham H Jackson, Gareth J Morgan, Faith E Davies, et al.
Cellular & Molecular Immunology|January 5, 2022
Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primatesStéphane Pillet, Prabhu S Arunachalam, Guadalupe Andreani, et al.
Journal of the American Medical Informatics Association : JAMIA|October 1, 2021
Enhancing the use of EHR systems for pragmatic embedded research: lessons from the NIH Health Care Systems Research CollaboratoryRachel L Richesson, Keith S Marsolo, Brian J Douthit, et al.
Annals of the Rheumatic Diseases|July 14, 2026
Zanubrutinib monotherapy for IgG4-related head and neck diseaseMatthew C Baker, Saurabh Gawde, Audra Horomanski, et al.
Haematologica|July 23, 2013
Comprehensive whole-genome sequencing of an early-stage primary myelofibrosis patient defines low mutational burden and non-recurrent candidate genesJason D Merker, Krishna M Roskin, Dana Ng, et al.
Pageof 123